Quest Diagnostics provides comprehensive anatomic pathology services including gynecological cytology, non-gynecological cytology including fine needle aspiration cytology, tissue pathology (histology), hematopathology, and molecular pathology (immunopathology). Our policies and procedures reflect our values and commitment to Quality. The professional staff strives to provide timely and accurate interpretations combined with superior service to our clients.
The following outline reviews the components in facilities that provide on-site Anatomic Pathology services.
Documents below are in PDF Format, if you do not have Acrobat Reader, you may download the latest version from Adobe's site. |
Innovative Test Offerings
Cervical Cancer Screening
Quest Diagnostics not only provides clinicians with the highest level of quality products and services that are critical in cervical cancer screening and management, but we also serve as a consultative resource providing the latest technological and medical advancements in the increasingly dynamic area.
Liquid-Based Cytology
Quest Diagnostics offers physicians the Power of Choice in liquid-based cytology by affording clinicians two liquid-based cytology product options: the SurePath™ liquid-based Pap test and the ThinPrep® Pap Test™. Both products are supported by data demonstrating improved diagnostic sensitivity when compared to the conventional Pap smear.
High-Risk HPV DNA Testing
Since High-Risk HPV DNA is a necessary cause of cervical cancer and can provide valuable information regarding a patient’s risk, Quest Diagnostics offers High-Risk HPV DNA Testing as a primary screening option in conjunction with Pap tests for women age 30 and older, as a triage to ASC-US results, or as a separate test.
Continuous Quality Improvement
Standardized Policies and Procedures
Quality Improvement starts with policies and procedures that lay the groundwork for a disciplined approach to specimen preparation, analysis and reporting.
Quality Control
Our extensive QC procedures enhance the basic CLIA requirements and include rescreening Paps from all women who are at High Risk of developing cervical cancer, review of all presumptively abnormal Paps by a senior Cytotechnologist and/or Pathologist, required review of unusual or instructive cases at a multiheaded microscope, random review of Pathologists' diagnoses, pre-employment testing of all potential new hires, and many other policies.
Proficiency Testing
The professional staff participates in quarterly Proficiency Testing appropriate to their duties and monitored by the CAP.
Six Sigma Error Reductions
Quest Diagnostics has embarked on an initiative to reduce error rates to Virtual Perfection using Six Sigma techniques so successfully used by other industries. We plan to reduce errors, such as missed pickups or amended reports, to nearly undetectable levels.
Qualifications
Certification and Licensure
All Quest Diagnostics' AP facilities are accredited by the College of American Pathologists (CAP) and certified by CLIA and Medicare. We are inspected regularly by state agencies and other regulatory agencies.
Personnel
All employed Quest Diagnostics professional staff (Cytotechnologists and Pathologists) is properly certified, licensed and adheres to continuing education requirements. In addition to our general Pathology Staff, we employ many Board Certified Cytopathologists, Dermatopathologists, and Hematopathologists.
< Back to Diagnostic Testing & Services